School of Physical Science and Technology, ShanghaiTech University , Shanghai 201210, China.
Department of Microbiology and Immunology, Indiana University, School of Medicine-Northwest , Gary, Indiana 46408, United States.
J Am Chem Soc. 2017 Mar 15;139(10):3790-3795. doi: 10.1021/jacs.6b13317. Epub 2017 Mar 2.
Staphylococcus aureus, a major human pathogen, has been the cause of serious infectious diseases with a high mortality rate. Although genetics is a key means to study S. aureus physiology, such as drug resistance and pathogenesis, genetic manipulation in S. aureus is always time-consuming and labor-intensive. Here we report a CRISPR/Cas9 system (pCasSA) for rapid and efficient genome editing, including gene deletion, insertion, and single-base substitution mutation in S. aureus. The designed pCasSA system is amenable to the assembly of spacers and repair arms by Golden Gate assembly and Gibson assembly, respectively, enabling rapid construction of the plasmids for editing. We further engineered the pCasSA system to be an efficient transcription inhibition system for gene knockdown and possible genome-wide screening. The development of the CRISPR/Cas9-mediated genome editing and transcription inhibition tools will dramatically accelerate drug-target exploration and drug development.
金黄色葡萄球菌是一种主要的人类病原体,可导致死亡率很高的严重传染病。尽管遗传学是研究金黄色葡萄球菌生理机能(如耐药性和发病机制)的关键手段,但金黄色葡萄球菌的遗传操作一直以来都既耗时又费力。在这里,我们报告了一个 CRISPR/Cas9 系统(pCasSA),它可用于快速有效地编辑金黄色葡萄球菌基因组,包括基因缺失、插入和单碱基替换突变。设计的 pCasSA 系统可通过 Golden Gate 组装和 Gibson 组装分别对间隔物和修复臂进行组装,从而能够快速构建用于编辑的质粒。我们还进一步设计了 pCasSA 系统作为一种高效的转录抑制系统,可用于基因敲低和可能的全基因组筛选。CRISPR/Cas9 介导的基因组编辑和转录抑制工具的开发将极大地加速药物靶点的探索和药物开发。